In the news | 4th March 2022
Speed up your development pipeline and get your time back with digital transformation
The pandemic exposed the innovation divide between the digitally transformed and those that lagged. Strict regulation made life sciences and BioPharma organizations hesitant to modernize too quickly away from proven legacy methods and technologies, resulting in varying levels of digital transformation. But are they missing out?
Learn more in this article by Rehan Malik, IDBS, published in Drug Discovery and Development.
How to get more insight and value out of your Electronic Batch Record data with PIMS
Discover how PIMS can work synergistically with your existing Electronic Batch Record (EBR) software and why PIMS is a great alternative.
New process definition capabilities in PIMS further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers
New process definition capabilities in PIMS 5.1, further enhance quality assurance and “right-first-time” initiatives for pharma manufacturers.
Tradeshow | European BioAnalysis Forum | Nov 2023
Speak to our experts to learn how an innovative approach to transform your bioanalytical operations and to improve data quality, productivity and compliance, according to industry standards such as ICH M10 standards
Software validation keeps GxP systems current and speeds up time-to-market
Requirements to maintain a GxP environment means researchers must conduct software validation on any updated software so it continues to meet users’ needs.